Official Name:
- EN: Guangzhou Concord Cancer Center (GCCC)
- CN: 广州泰和肿瘤医院
Country, City, Address:
China, Guangdong Province, Guangzhou City, Huangpu District, Sino‑Singapore Guangzhou Knowledge City, No. 9 Ciji Road (No. 9 Ciji Road, Sino‑Singapore Guangzhou Knowledge City, Huangpu District, Guangzhou, 510555).
Nearest airport: Guangzhou Baiyun (CAN), ~50–60 minutes by car.
Metro: Zhicheng Station (Line 14, Knowledge City branch).
Year of Establishment:
Opened in June 2021 — confirmed by UICC and CancerFax. The project was initiated by Concord Medical Services Holdings Limited in collaboration with Sun Yat‑sen University Cancer Center and designed under the guidance of MD Anderson Cancer Center. Proton equipment installation was completed in September 2020; clinical trials began in November 2022; the operating license for the proton therapy equipment was granted in September 2024.
Type of Clinic:
Private tertiary‑level oncology hospital (Grade 3A). The largest private oncology hospital in China. Campus area: 50 acres (100,000 sq. m); planned bed capacity: 400. Combines clinical treatment, screening, research, and education.
Main Specializations:
| Specialty | Details |
|---|---|
| Proton Beam Therapy | Flagship service; the sole proton therapy provider in South China |
| Medical Oncology | Chemotherapy, targeted therapy, immunotherapy |
| Radiation Oncology (Photon) | Full spectrum of photon radiotherapy delivered via 15 devices |
| Surgical Oncology | Surgical treatment of various tumor types |
| Oncologic Imaging | Largest independent oncologic imaging center in China |
| Pediatric Oncology | Proton therapy for children to minimize radiation exposure to developing tissues |
| Precision Pathology | Fully digital remote pathology platform with integration of global expert review |
Key Technologies:
- Varian ProBeam® proton therapy system with superconducting cyclotron: 4 proton rooms with 360° gantries, pencil beam scanning (PBS), energy range 70–250 MeV, sub‑millimeter accuracy. The only proton therapy system in South China.
- IBA Proteus® PLUS: second proton platform; combined, the center operates 9 proton rooms, making it one of the world’s largest proton complexes.
- 15 photon devices for radiotherapy (including linear accelerators).
- Multidisciplinary Team (MDT) Model: each case reviewed by a multidisciplinary board according to international protocols.
- Integration with MD Anderson Cancer Center: clinical protocols, treatment planning, and staff training.
- Bragg Peak Principle: proton beam releases maximum energy precisely at the tumor, minimizing damage to surrounding healthy tissues.
Conditions Treated:
| Condition Group | Specific Diagnoses / Focus Areas |
|---|---|
| Primary Indications for Proton Therapy | Breast cancer, prostate cancer, head and neck cancers (including nasopharyngeal carcinoma), lung cancer, liver cancer |
| Pediatric Cancers | Tumors suitable for proton therapy; emphasis on minimizing long‑term side effects in growing children |
| Brain and CNS Tumors | |
| Tumors Near Critical Organs | Tumors adjacent to the optic nerve, spinal cord, liver, pancreas |
| Rare and Complex Tumors | Managed by a multidisciplinary team |
| Combined Cases | Requiring simultaneous surgical, medical, and radiation treatment |
Clinical Outcomes:
In its first 19 months of operation, the Proton Therapy Center treated over 1,000 patients (more than 800 by April 2026; over 1,000 by July 2026). Patients came from more than 20 countries. Daily volume: over 100 proton therapy sessions.
International Center:
Yes. GCCC has a dedicated department for international patients. Services include pre‑trip review of medical records and pathology reports, appointment scheduling, transport logistics, remote consultations, and follow‑up care. Partnerships: MD Anderson Cancer Center, Mayo Clinic, Sun Yat‑sen University Cancer Center. Memoranda of cooperation with Surabaya National Hospital (Indonesia) and the Agency for the Development of the Medical and Pharmaceutical Industry of Uzbekistan.
Languages:
Chinese (primary), English (via the international department). Russian, Arabic, and other languages are supported through third‑party coordinators (e.g., CancerFax, China Care Health Tours).
Doctors / Leading Specialists:
| Name | Position | Experience |
|---|---|---|
| Prof. Qian Chaonan | President and CEO of GCCC, Professor of Oncology | PhD, Shanghai Cancer Center (Fudan University, 1993). Clinical experience at Johns Hopkins Hospital, Fox Chase Cancer Center, and MD Anderson. Former head of Radiation Oncology at Shanghai Proton and Heavy Ion Hospital. Included in the top 2% of most cited scientists worldwide (2023–2024). Specialization: nasopharyngeal carcinoma, novel radiotherapy technologies |
| Prof. Fu Shen | Professor of Radiation Oncology, Lead Specialist, Proton Therapy Center | PhD (Fudan University). One of China’s leading experts in proton and heavy‑ion therapy. Founder and first director of the Shanghai Proton and Heavy Ion Therapy Center. Vice President of GCCC |
| Prof. Zheng Pingju | Medical Oncology | Member of the multidisciplinary team for diagnosis and comprehensive cancer treatment |
| Prof. Su Fengxi | Breast Oncology | Professor and clinical leader in breast cancer. Specialization: surgical and comprehensive treatment of breast cancer |
| Dr. Yang Jianyu | President and CEO (per GCCC website) | Member of the International Alliance Against Cancer and the Tumor Microenvironment Society of the Chinese Anti‑Cancer Association. Participated in developing national standards and guidelines |
| Dr. Li Pengfei | Oncologist, Lymphoma and Head & Neck Tumors Specialist | Graduate of the Cancer Prevention and Control Center, Sun Yat‑sen University |
Equipment:
| Equipment | Purpose |
|---|---|
| Varian ProBeam® (superconducting cyclotron) | Proton therapy: 4 rooms with 360° gantries, PBS, 70–250 MeV |
| IBA Proteus® PLUS | Second proton platform (9 proton rooms total) |
| 15 Photon Devices | Radiotherapy (linear accelerators, etc.) |
| PET‑CT | Oncologic imaging |
| Eclipse / Aria (Varian) | Treatment planning system and oncology information system |
| CBCT / 2D kV Imaging | Patient positioning verification during irradiation |
| Respiratory Gating System | Precise targeting of moving tumors (lungs, liver) |
| 6‑Axis Robotic Couch | Sub‑millimeter patient positioning accuracy |
Official Website:
- (English version) https://www.concord-hospital.org/
Contacts:
- Phone: 400‑830‑7338 (appointment line) / 020‑8184‑2480 (administrative office)
- Email:consultation@concord-hospital.org
Accreditations and Partnerships:
- Member of the Union for International Cancer Control (UICC)
- Member of PTCOG (Particle Therapy Co‑operative Group)
- Designed under the guidance of MD Anderson Cancer Center
- Partner of Mayo Clinic
- Partner of Sun Yat‑sen University Cancer Center
- Project investment: over CNY 3 billion (~USD 420 million)
Key Differentiator:
GCCC is the sole proton therapy provider in South China and the largest private oncology center in the country. Built to MD Anderson standards, it adheres to international treatment protocols.
The date of the last information verification: 06.10.2026
